These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 24461723

  • 1. Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
    Taksande BG, Kotagale NR, Gawande DY, Bharne AP, Chopde CT, Kokare DM.
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):955-63. PubMed ID: 24461723
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
    Deo GS, Dandekar MP, Upadhya MA, Kokare DM, Subhedar NK.
    Brain Res; 2010 Mar 08; 1318():77-86. PubMed ID: 20059983
    [Abstract] [Full Text] [Related]

  • 3. Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.
    Desai SJ, Borkar CD, Nakhate KT, Subhedar NK, Kokare DM.
    Neuroscience; 2014 Sep 26; 277():818-30. PubMed ID: 25106129
    [Abstract] [Full Text] [Related]

  • 4. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
    Kotagale NR, Paliwal NP, Aglawe MM, Umekar MJ, Taksande BG.
    Peptides; 2013 Sep 26; 47():7-11. PubMed ID: 23816796
    [Abstract] [Full Text] [Related]

  • 5. Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
    Rangani RJ, Upadhya MA, Nakhate KT, Kokare DM, Subhedar NK.
    Peptides; 2012 Feb 26; 33(2):317-28. PubMed ID: 22266216
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neuropeptide Y system in accumbens shell mediates ethanol self-administration in posterior ventral tegmental area.
    Borkar CD, Upadhya MA, Shelkar GP, Subhedar NK, Kokare DM.
    Addict Biol; 2016 Jul 26; 21(4):766-75. PubMed ID: 25929272
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
    Saurer TB, Ijames SG, Lysle DT.
    J Neuroimmunol; 2006 Aug 26; 177(1-2):18-26. PubMed ID: 16766046
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neuropeptide Y and its receptor analogs differentially modulate the immunoreactivity for neuronal or endothelial nitric oxide synthase in the rat brain following focal ischemia with reperfusion.
    Chen SH, Cheung RT.
    J Biomed Sci; 2005 Aug 26; 12(2):267-78. PubMed ID: 15942706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.